Eli Lilly's Amyvid is injected into patients who then get a PET scan. A negative diagnosis rules out Alzheimer's.
Monday, May 9, 2011
Chemical Highlight Alzheimer's Disease in the Brain
Current medications are most effective in the early stages of Alzheimer's disease. That's why the FDA may approve a new chemical that can highlight Alzheimer's signs in the brain.
Labels:
Alzheimer's Disease
Subscribe to:
Post Comments (Atom)
1 comment:
Always good to know that people are diligently working on cures and medications to treat these dreaded diseases. It's hard to imagine being a victim, but unfortunately, some of will be.
Post a Comment